XML 28 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments and Fair Value Measurements
6 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Financial Instruments and Fair Value Measurements
Financial Instruments and Fair Value Measurements
The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at March 31, 2016 and September 30, 2015 are classified in accordance with the fair value hierarchy in the following tables:
 
 
 
Basis of Fair Value Measurement
(Millions of dollars)
March 31, 2016
Total
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
 
Significant Other
Observable
Inputs (Level 2)
 
Significant
Unobservable
Inputs (Level 3)
Assets
 
 
 
 
 
 
 
Institutional money market investments
$
477

 
$
477

 
$

 
$

Interest rate swaps
24

 

 
24

 

Forward exchange contracts
22

 

 
22

 

Total Assets
$
523

 
$
477

 
$
46

 
$

Liabilities
 
 
 
 
 
 
 
Forward exchange contracts
$
9

 
$

 
$
9

 
$

Commodity forward contracts
5

 

 
5

 

Interest rate swaps
3

 

 
3

 

Contingent consideration liabilities
57

 

 

 
57

Total Liabilities
$
73

 
$

 
$
16

 
$
57

 
 
 
Basis of Fair Value Measurement
(Millions of dollars)
September 30,
2015
Total
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
 
Significant Other
Observable
Inputs (Level 2)
 
Significant
Unobservable
Inputs (Level 3)
Assets
 
 
 
 
 
 
 
Institutional money market investments
$
147

 
$
147

 
$

 
$

Interest rate swaps
19

 

 
19

 

Forward exchange contracts
13

 

 
13

 

Total Assets
$
179

 
$
147

 
$
32

 
$

Liabilities
 
 
 
 
 
 
 
Forward exchange contracts
$
21

 
$

 
$
21

 
$

Commodity forward contracts
10

 

 
10

 

Contingent consideration liabilities
77

 

 

 
77

Total Liabilities
$
108

 
$

 
$
30

 
$
77


The Company’s institutional money market accounts permit daily redemption and the fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. The Company’s remaining cash equivalents were $1.219 billion and $1.277 billion at March 31, 2016 and September 30, 2015, respectively. Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The cash equivalents consist of liquid investments with a maturity of three months or less and the short-term investments consist of instruments with maturities greater than three months and less than one year.
The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.
Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was $11.5 billion and $11.6 billion at March 31, 2016 and September 30, 2015, respectively. During the first quarter of fiscal year 2016, the Company reclassified $500 million of 1.75% notes due on November 8, 2016 from Long-Term Debt to Short-term debt. During the third quarter of fiscal year 2015, the Company reclassified $750 million of floating rates due on June 15, 2016 from Long-Term Debt to Short-term debt. The fair value of reclassified notes was $1.3 billion and $750 million at March 31, 2016 and September 30, 2015, respectively.
The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned with regard to achievement of the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured each reporting period based upon increases or decreases in the probability of the contingent payments. The change to the contingent consideration liability as of March 31, 2016 reflected the impact of a net decrease recorded in the second quarter of $22 million in the fair value of contingent consideration liabilities associated with certain product development milestones.
The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period. There were no transfers in and out of Level 1, Level 2 or Level 3 measurements for the three and six months ended March 31, 2016 and 2015.